From Algorithm to Enterprise: An Investor’s Guide to Commercializing Medical AI

Speaker details

Marta G. Zanchi, Ph.D. is the Founder and Managing Partner of Nina Capital, an international venture capital firm specializing in pre-seed and seed-stage healthcare technology investments. She possesses a deep technical and academic background in medical systems development and health technology innovation, having spent years engaging in academic endeavors at Stanford University before transitioning to venture capital. Along the way, she founded numerous programs and innovation initiatives, as well as a medical device company that ultimately IPO'd in the NASDAQ (RNXT). Through Nina Capital, Dr. Zanchi has invested in and guided multiple university spinoffs, partnering with founders to bring complex health technologies from the lab to the market. Her unique perspective, combining academic rigor with the strategic lens of a seasoned early-stage investor, enables her to identify and support the critical success factors necessary for academic innovations to succeed as commercial enterprises.

Registration Required

https://us02web.zoom.us/meeting/register/X3lIdy6uTeCWI0I4n43rvw 

Learning objectives

By the end of this session, participants will be able to: 

• Explain the key challenges involved in translating academic and clinical medical AI innovations into successful commercial ventures.
• Identify the critical success factors required to transform an AI solution into a sustainable health technology business.
• Describe what early-stage investors look for when evaluating new medical AI ventures.
• Recognize common pitfalls to avoid when commercializing medical AI solutions.
• Understand the key steps and considerations in bridging the gap between research innovation and real-world commercial impact.

Seminar contact